Regional Health Properties, Inc. (RHEP) Stock Price & Analysis
Regional Health Properties, Inc. (RHEP) closed at USD 1 on Friday, October 23, 2026, down 2.91% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 1.03; the Oct 23, 2026 session ranged USD 1.02–1.02 on volume of 10 shares. Market capitalization is $3.92M, with a 52-week range of USD 0.91–1.55 (OQB). Source: Nexqual, retrieved October 24, 2026 at 12:39 UTC.
Also available as compact Markdown for AI agents: nexqual.com/RHEP.md
Key facts (RHEP)
- Last four reported quarters (through Jun 30, 2026): revenue $81.5M, net income $4.1M (5.0% margin), free cash flow -$3.9M (SEC filings).
- Insider open-market sales, last ~7 months: 1 Form 4 filings, $6K; 1 not under a Rule 10b5-1 plan ($6K); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Insider open-market purchases, last ~7 months: 3 Form 4 filings, $77K; 0 by opportunistic insiders, 0 by routine insiders.
- Analysts: None.
- Total return with dividends: 1Y -28.1% vs S&P 500 +13.4%; 5Y -84.7% vs S&P 500 +76.9%.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (RHEP)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $26.7M | $35.9M | $17.2M | $18.3M | $53.2M | $81.5M |
| Gross profit | — | — | — | — | $46.2M | — |
| Operating income | $2.5M | -$6.8M | -$821K | $161K | $1.7M | $1.6M |
| Net income | -$1.2M | -$6.9M | -$3.9M | -$3.2M | $3.4M | $4.1M |
| EPS (diluted) | -$5.87 | -$8.93 | $21.05 | -$1.73 | $1.09 | — |
| Free cash flow | $4.8M | -$3.9M | $2.8M | $1.4M | -$3.1M | -$3.9M |
| Gross margin | — | — | — | — | 86.9% | — |
| Operating margin | 9.5% | -19.0% | -4.8% | 0.9% | 3.1% | 1.9% |
| Net margin | -4.4% | -19.1% | -22.7% | -17.6% | 6.3% | 5.0% |
| Revenue growth | +51.8% | +34.6% | -52.2% | +6.8% | +189.9% | — |
| Cash + short-term investments | $6.8M | $800K | $1.0M | $582K | $3.0M | — |
| Total debt | $52.9M | $52.2M | $50.7M | $49.7M | $43.2M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (RHEP)
P/E at fiscal year-ends: Dec 2025 0.0x.
Insider sales (SEC Form 4, open-market, last ~7 months) (RHEP)
0 of 1 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-06-05…2026-06-15 | Radoff Bradley Louis | 5,100 | $6K | 1.5% | No | Too little history (no open-market trades in 2023–2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Insider purchases (SEC Form 4, open-market, last ~7 months) (RHEP)
3 purchases, $77K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-05-27…2026-06-05 | Morrison Brent | CEO and President | 20,000 | $28K | 1.38 | Too little history (no open-market trades in 2024) |
| 2026-05-20…2026-05-21 | Morrison Brent | CEO and President | 17,000 | $30K | 1.79 | Too little history (no open-market trades in 2024) |
| 2026-04-13…2026-04-29 | Radoff Bradley Louis | 14,420 | $19K | 1.33 | Too little history (no open-market trades in 2023–2025) |
Analysts (RHEP)
Consensus None.
Total return (dividends reinvested) (RHEP)
| 1Y (from 2025-10-24) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | -28.1% | -84.7% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | -28.1% | -31.3% |
| Volatility (annualized) | 67.8% | 86.5% |
| Max drawdown | -36.7% (Dec 2025→Sep 2026) | -87.0% (Nov 2021→Sep 2026) |
RHEP revenue by business segment (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Healthcare Services | $14.0M | 57.3% | +59.6% |
| Pharmacy Service | $9.7M | 39.5% | — |
| Real Estate Services | $786,000 | 3.2% | -38.7% |
| Total revenue | $24.4M | 100% | — |
RHEP revenue by product line (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Health Care Patient Service | $14.0M | 57.3% | +59.6% |
| Pharmacy Revenues | $9.6M | 39.4% | — |
| Rental Revenue | $801,000 | 3.3% | -37.6% |
| Total revenue | $24.4M | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
RHEP analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter | — | — | — | $0 | — |
| Next quarter | — | — | — | $0 | — |
| Current fiscal year | — | — | — | $0 | — |
| Next fiscal year | — | — | — | $0 | — |
Key Statistics (as of October 24, 2026 at 12:39 UTC)
| Price | USD 1 |
|---|---|
| Change | ▼ 2.91% (down) |
| Previous Close | USD 1.03 |
| Open | USD 1.02 |
| Day Range | USD 1.02 – 1.02 |
| 52-Week Range | USD 0.91 – 1.55 |
| Volume | 10 shares |
| Market Cap | $3.92M |
| Exchange | OQB |
Technical Analysis (RHEP)
Nexqual's technical model rates RHEP "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of October 24, 2026 at 12:39 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 46.81 (neutral) |
| vs SMA50 | Below (USD 1.03) |
| MACD | -0 (negative) |
Analyst Ratings (RHEP)
Wall Street analysts rate RHEP "None", per Nexqual as of October 24, 2026 at 12:39 UTC.
| Consensus Rating | None |
|---|
Earnings (RHEP)
Source: Nexqual, October 24, 2026 at 12:39 UTC.
Financials & Fundamentals (RHEP)
| Total Revenue | $80.80M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +150.90% |
| Gross Margin | +29.29% |
| Operating Margin | -0.89% |
| Profit Margin | +5.04% |
| Debt / Equity | 14.34 |
| Current Ratio | 0.65 |
| Total Cash | $1.73M |
| Total Debt | $42.72M |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | -$3.94M (-4.8% of revenue) |
Source: Nexqual, October 24, 2026 at 12:39 UTC.
Financial Health Score (RHEP)
Nexqual rates Regional Health Properties, Inc.'s overall financial health "Weak" across five dimensions, as of October 24, 2026 at 12:39 UTC.
| Growth | Mixed — Revenue +4.2% YoY (annual), slow |
|---|---|
| Profitability | Weak — Gross margin 29%, operating -1% (last 12 months) |
| Balance Sheet | Critical — $2M cash and investments vs $43M debt (Jun 2026, SEC) |
| Cash Flow | Weak — FCF negative: -$4M (last 4 quarters to Jun 2026, SEC), burning cash |
| Efficiency | Mixed — No data |
Ownership (RHEP)
| Insider Ownership | +18.59% |
|---|---|
| Institutional Ownership | +8.32% |
| Shares Outstanding | 3.92M |
| Float | 2.76M |
| Short % of Float | +6.51% |
Source: Nexqual, October 24, 2026 at 12:39 UTC.
From Regional Health Properties, Inc.'s Latest SEC 10-K Filing (filed 2026-04-02)
Key Strengths & Strategy (as disclosed to the SEC)
- The Merger expanded Regional's operating platform and accelerated the Company's transition toward a vertically integrated healthcare services model.
Legal & Regulatory Risks (Item 1A, quoted)
- The costs of being publicly owned may strain our resources and impact our business, financial condition, results of operations and prospects.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PRPO | Precipio, Inc. | USD 20.01 | ▼ 2.91% |
| IHT | InnSuites Hospitality Trust Sha | USD 1.11 | ▼ 0% |
| LEDS | SemiLEDS Corporation | USD 1.97 | ▲ 2.07% |
| PWCM | PowerCompute, Inc. | USD 0.61 | ▲ 0.94% |
| UUU | Universal Safety Products, Inc. | USD 5.29 | ▲ 3.73% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 24, 2026 at 12:39 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt